The global hydrocephalus shunt market is poised for steady expansion, with Future Market Insights (FMI) projecting a market ...

A team in Pittsburgh received a $2.3 million grant to fast-track the development and clinical transition of a minimally ...

Once the decision to place a VP shunt has been made, valve selection is of vital importance. There are many valve designs available today. As of 1999 there were at least 127 commercially available ...

CereVasc, Inc. announced the initial results of its United States pilot clinical study of the CereVasc eShunt system in the ...

Boston-based CereVasc designed eShunt for treating normal pressure hydrocephalus (NPH). This study evaluates the technology ...

The eShunt System is the only endovascular shunt and the first new treatment option developed for NPH since VP shunts were introduced more than 70 years ago. Roughly 800,000 people in the US alone ...

Hazel was fitted with a ventriculoperitoneal shunt (VPS) to drain the build ... “There are a small number of case reports published about hydrocephalus in foxes, but none about surgery for ...

Cerebrospinal fluid (CSF) shunt infections are a significant complication associated with the surgical placement of shunts, which are devices used to manage conditions like hydrocephalus.

The hospital bulletin revealed that Ramamurthy Naidu had been suffering from non-communicating normal pressure hydrocephalus (a buildup of fluid in the brain) and post VP shunt complications ...

Idiopathic normal pressure hydrocephalus (INPH ... INPH is to determine if surgical implantation of a ventriculoperitoneal (VP) shunt will be beneficial. VP shunting is now a common neurosurgical ...